190 related articles for article (PubMed ID: 28017218)
21. Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?
Delmont E; Benvenutto A; Grimaldi S; Duprat L; Philibert M; Pouget J; Grapperon AM; Salort-Campana E; Sévy A; Verschueren A; Attarian S
Clin Neurophysiol; 2016 Mar; 127(3):1891-4. PubMed ID: 26750580
[TBL] [Abstract][Full Text] [Related]
22. Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Draak TH; Gorson KC; Vanhoutte EK; van Nes SI; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
Eur J Neurol; 2016 Jul; 23(7):1248-53. PubMed ID: 27129110
[TBL] [Abstract][Full Text] [Related]
23. Vestibular impairment in chronic inflammatory demyelinating polyneuropathy.
Akdal G; Tanrıverdizade T; Şengün İ; Bademkıran F; Koçoğlu K; Yüceyar AN; Ekmekçi Ö; Karasoy H; Halmágyi GM
J Neurol; 2018 Feb; 265(2):381-387. PubMed ID: 29260355
[TBL] [Abstract][Full Text] [Related]
24. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104
[TBL] [Abstract][Full Text] [Related]
25. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.
Dunnigan SK; Ebadi H; Breiner A; Katzberg HD; Barnett C; Perkins BA; Bril V
PLoS One; 2014; 9(2):e89344. PubMed ID: 24586703
[TBL] [Abstract][Full Text] [Related]
26. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
Wadwekar V; Kalita J; Misra UK
Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
[TBL] [Abstract][Full Text] [Related]
27. The value of MUNIX as an objective electrophysiological biomarker of disease progression in chronic inflammatory demyelinating polyneuropathy.
Okhovat AA; Advani S; Ziaadini B; Panahi A; Salehizadeh S; Nafissi S; Haghi Ashtiani B; Rajabally YA; Fatehi F
Muscle Nerve; 2022 Apr; 65(4):433-439. PubMed ID: 35040150
[TBL] [Abstract][Full Text] [Related]
28. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
29. Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Basta I; Bozovic I; Kacar A; Nikolic A; Dominovic-Kovacevic A; Vukojevic Z; Martic V; Stojanov A; Djordjevic G; Petrovic M; Stojanovic M; Peric S
J Peripher Nerv Syst; 2018 Sep; 23(3):178-182. PubMed ID: 29999199
[TBL] [Abstract][Full Text] [Related]
30. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
Klehmet J; Beutner S; Hoffmann S; Dornauer M; Paul F; Reilmann R; Brandt AU; Meisel A
BMC Neurol; 2019 Jun; 19(1):118. PubMed ID: 31176377
[TBL] [Abstract][Full Text] [Related]
31. Clinical correlates of fatigue in chronic inflammatory demyelinating polyneuropathy.
Lawley A; Abbas A; Seri S; Rajabally YA
Muscle Nerve; 2020 Aug; 62(2):226-232. PubMed ID: 32388856
[TBL] [Abstract][Full Text] [Related]
32. Analysis of relapse by inflammatory Rasch-built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy.
Merkies ISJ; van Schaik IN; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR;
J Peripher Nerv Syst; 2022 Jun; 27(2):159-165. PubMed ID: 35266243
[TBL] [Abstract][Full Text] [Related]
33. Predicting long-term trends in inflammatory neuropathy outcome measures using latent class modelling.
Keh RYS; Selby DA; Jones S; Gosal D; Lavin T; Lilleker JB; Carr AS; Lunn MP
J Peripher Nerv Syst; 2022 Mar; 27(1):84-93. PubMed ID: 34936164
[TBL] [Abstract][Full Text] [Related]
34. Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies.
Merkies IS; Schmitz PI
J Neurol Neurosurg Psychiatry; 2006 Aug; 77(8):970-2. PubMed ID: 16549419
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies.
Grimm A; Vittore D; Schubert V; Lipski C; Heiling B; Décard BF; Axer H
Clin Neurophysiol; 2016 Jul; 127(7):2618-24. PubMed ID: 27291881
[TBL] [Abstract][Full Text] [Related]
36. Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance.
Merkies IS; van Nes SI; Hanna K; Hughes RA; Deng C
J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1194-9. PubMed ID: 20647554
[TBL] [Abstract][Full Text] [Related]
37. Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post-hoc analysis of the immunoglobulin overtreatment in CIDP trial.
van Veen R; Wieske L; Lucke I; Adrichem ME; Merkies ISJ; van Schaik IN; Eftimov F
J Peripher Nerv Syst; 2022 Jun; 27(2):144-158. PubMed ID: 35507446
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and determinants of pain in chronic inflammatory demyelinating polyneuropathy: Results from the German INHIBIT registry.
Mork H; Motte J; Fisse AL; Grüter T; Brünger J; Stoykova Z; Bulut Y; Athanasopoulos D; Sturm D; Tegenthoff M; Gold R; Enax-Krumova E; Pitarokoili K
Eur J Neurol; 2022 Jul; 29(7):2109-2120. PubMed ID: 35357725
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
Kalita J; Misra UK; Yadav RK
Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
[TBL] [Abstract][Full Text] [Related]
40. Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
Abraham A; Alabdali M; Qrimli M; Albulaihe H; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
PLoS One; 2015; 10(10):e0139674. PubMed ID: 26461125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
